When doctors check a child's risk for future heart problems, they often look at a blood marker called Lipoprotein(a), or Lp(a). For kids with type 1 diabetes, this number is especially important. But what if that number isn't a fixed score, but one that can bounce around? A new study followed 287 children and adolescents with type 1 diabetes at a Swiss hospital for a median of over six years. They found that Lp(a) levels were surprisingly changeable. About 32% of the kids had fluctuations where their levels swung by more than half of their maximum recorded value. Even more telling, nearly 12% of participants moved across a key medical threshold (300 mg/L) used to classify higher cardiovascular risk during the study period. The levels also seemed to follow a pattern, peaking between ages 10 and 13 before declining, and showing a modest seasonal uptick in autumn and winter. This is an observational study from a single medical center, so we can't say these fluctuations directly cause different health outcomes. But it raises a crucial question for families and doctors: if a risk marker can vary this much, does relying on one blood test give us the clearest picture? The findings suggest that repeated checks, especially during the turbulent adolescent years, might paint a more accurate portrait of a child's long-term heart health trajectory.
Does a child's heart risk marker change over time? New study finds surprising variability
Photo by Navy Medicine / Unsplash
What this means for you:
A heart risk marker in kids with diabetes can change significantly, suggesting one test may not be enough. More on Cardiovascular Disease
Narrative review of transposable element methylation in autoimmune diseases Genetic elements may link autoimmune diseases to inflammation
Frontiers · May 1, 2026
Perspective review discusses chronic air pollution effects on children and older adults in Puerto Rico Air pollution may change your body’s microbes and raise cancer risk
Frontiers · May 1, 2026
Meta-analysis finds home-based exercise improves VO2 peak in CVD and healthy adults Home Exercise Boosts Heart Health in People With and Without Cardiovascular Disease
· May 1, 2026
Semaglutide reduces insulin dose in adults with type 1 diabetes and obesity Semaglutide Cuts Insulin Needs By Half In Type 1 Diabetes
Diab Care · May 1, 2026